Cancer incidence and mortality in Chukotka, 1997–2010

Figures & data

Table I. Top 5 ranking cancers in Chukotka and Russia, 1997–2010

Incidence Site	Chukotka		Russia		Mortality Site	Chukotka		Russia
	Percent	Rank	Percent	Rank		Percent	Rank	Percent	Rank
	Male					Male
Lung/trachea/bronchi	26.3	1	22.4	1	Lung/trachea/bronchi	32.0	1	28.9	1
Stomach	12.1	2	11.4	2	Stomach	13.3	2	14.3	2
Lymphoid/HT	6.3	3	4.8	5	Oesophagus	7.3	3	3.3	10
Oesophagus	5.8	4	2.6	11	Liver/bile ducts	6.1	4	3.0	13
Rectum/RS/anus	5.4	5	4.6	6	Rectum/RS/anus	5.3	5	5.1	5
Colon	4.5	7	5.3	4	Colon	5.0	6	5.3	3
Prostate	2.7	9	7.5	3	Prostate	1.4	15	5.3	4
	Female					Female
Breast	22.7	1	19.7	1	Lung/trachea/bronchi	21.1	1	6.5	4
Lung/trachea/bronchi	9.1	2	4.1	8	Breast	11.6	2	17.0	1
Cervix	9.1	3	5.2	5	Stomach	11.2	3	12.7	2
Colon	7.7	4	6.9	3	Colon	10.4	4	8.9	3
Rectum/RS/anus	5.9	5	4.8	7	Oesophagus	5.5	5	1.2	17
Stomach	5.6	6	7.8	2	Rectum/RS/anus	4.0	8	6.4	5
Uterus	5.0	7	6.8	4	Uterus	4.4	6	4.7	9

Appendix Table I. Average annual number of cases, percent, crude and age-standardized cancer incidence rates (ASIR) per 100,000 among men in Chukotka and Russian Federation, 1997–2010

	Chukotka					Russia
Male	Cases/year	%	Crude	ASIR	95% CI	Cases/year	%	Crude	ASIR	95% CI
Lips	0.5	0.8	1.4	1.5	0–4.3	3242.5	1.5	4.8	3.9	3.6–3.8
Tongue	0.9	1.4	2.9	2.7	0–7.2	1717.2	0.8	2.6	2.1	2–2.2
Salivary glands	0.3	0.4	0.9	0.6	0–1.8	575	0.3	0.9	0.7	0.6–0.8
Other parts of oral cavity	1	1.6	3.7	6.9	0–19.7	2637.1	1.2	4	3.2	3.1–3.3
Oropharynx	0.8	1.2	2.4	4.6	0–13.9	1681.8	0.8	2.5	2.1	1.9–2.1
Nasopharynx	0.4	0.7	1.5	1.5	0–4.3	372.5	0.2	0.6	0.5	0.4–0.5
Laryngopharynx	0.7	1	2.3	4.5	0–13	1524.6	0.7	2.3	1.9	1.8–2
Oesophagus	3.6	5.8	11.9	13.2	0–28.3	5648.4	2.6	8.5	6.9	6.6–7
Stomach	7.8	12.1	25.5	47.5	2.3–88.3	25261.1	11.4	37.8	30.3	29.2–30
Colon	2.8	4.5	9.5	9	0–18.1	11836.6	5.3	17.8	14.2	14.1–14.6
Rectum/RSJ/anus	3.3	5.4	11.8	16.1	0–37.4	10283.5	4.6	16.6	13.2	13.1–13.6
Liver/bile ducts	2.1	3.2	7.3	10.1	0–24.6	3800.1	1.7	5.7	4.6	4.4–4.7
Pancreas	1.5	2.3	5.4	7.9	0–21.5	6939.8	3.1	10.4	8.4	8.1–8.5
Larynx	1.5	2.6	4.7	4	0–10	6555.6	3	9.8	7.9	7.6–8
Lung/trachea/bronchi	16.7	26.3	56.2	63.8	24.1–106.9	49480.5	22.4	74.2	59.6	58–59.1
Bones/cartilages	0.6	0.9	2	4.6	0–14	1170.5	0.5	1.8	1.6	1.4–1.6
Skin melanoma	0.5	0.8	1.9	1.2	0–3.8	2664.5	1.2	4	3.2	3.1–3.4
Other MSN	1.7	2.6	6	10.2	0–24.8	20505.7	9.2	30.8	24.7	24.5–25.2
Connective/other ST	0.4	0.7	1.2	1.2	0–2.6	1528.1	0.7	2.3	2	1.9–2.1
Prostate	1.8	2.7	6.3	10.1	0–24.6	16839	7.5	25.4	20.1	20.5–21.1
Kidneys	3	4.6	11.2	12.4	0–28.9	8654.1	3.9	13	10.5	10.5–11
Urinary bladder	1.8	2.6	6.5	9.5	0–24.4	9911.3	4.5	14.9	11.9	11.7–12.2
Brain/CNS	1.1	1.7	3.9	3.4	0–8.9	3015.3	1.4	4.6	4	4–4.3
Thyroid gland	0.8	1.1	2.9	2.2	0–6.2	1191	0.5	1.8	1.4	1.4–1.6
Lymphoid/HT	3.8	6.3	11.8	10.3	0–21.8	10690.1	4.8	16.1	14.1	13.9–14.4
Other sites	4.1	6.5	0	0	0	14013.8	6.3	0	0	0
All sites	63.3	100	214.5	277.3	185.2–378.4	221739.3	100	332.8	269	267.5–269.8

RSJ=rectum-sigmoid junction, MSN=malignant skin neoplasm, ST=soft tissues, HT=hematopoietic tissues, CNS=central nervous system.

Appendix Table II. Average annual number of cases, percent, crude and age-standardized cancer incidence rates (ASIR) per 100,000 among women in Chukotka and Russian Federation, 1997–2010

	Chukotka					Russia
Female	Cases/year	%	Crude	ASIR	95% CI	Cases/year	%	Crude	ASIR	95% CI
Lips	0.0	0.0	0.0	0.0	0–0	1063.0	0.4	1.4	0.6	0.6–0.6
Tongue	0.2	0.3	0.6	0.4	0–1.3	535.0	0.2	0.7	0.4	0.4–0.5
Salivary glands	0.1	0.1	0.3	1.1	0–3.6	524.0	0.2	0.7	0.4	0.4–0.5
Other parts of oral cavity	0.4	0.8	1.5	2.0	0–5.9	677.4	0.3	0.9	0.5	0.5–0.6
Oropharynx	0.3	0.4	0.9	0.6	0–1.3	195.2	0.1	0.3	0.2	0.2–0.2
Laryngopharynx	0.0	0.0	0.0	0.0	0–0	107.2	0.0	0.1	0.1	0.1–0.1
Oesophagus	1.5	2.9	5.4	9.3	0–25.2	1747.0	0.7	2.3	1.1	1–1.1
Stomach	2.9	5.6	10.7	12.3	0–26.1	19100.5	7.8	24.9	13.0	12.5–12.9
Colon	4.3	7.7	16.0	18.8	0–40.2	17046.5	6.9	22.3	11.7	11.6–12
Rectum/RSJ/anus	3.1	5.9	11.3	13.0	0–28.7	11803.3	4.8	15.4	8.4	8.3–8.6
Liver/bile ducts	0.6	1.1	1.9	3.4	0–9.3	2986.3	1.2	3.9	2.1	2–2.1
Pancreas	0.6	1.0	2.4	2.6	0–7.1	6644.2	2.7	8.7	4.4	4–4.2
Larynx	0.5	0.8	2.1	2.2	0–6.6	390.2	0.2	0.5	0.3	0.3–0.3
Lung/trachea/bronchi	4.9	9.1	18.6	24.9	1.9–51	10079.8	4.1	13.1	7.0	6.8–7.1
Bones/cartilages	0.3	0.4	0.9	1.2	0–2.5	923.7	0.4	1.2	1.0	0.9–1
Skin melanoma	1.1	2.1	3.6	2.3	0–5.5	4427.8	1.8	5.8	3.7	3.7–3.9
Other MSN	2.5	4.4	9.3	9.4	0–20	33018.8	13.3	43.1	21.8	21.7–22.2
Connective/other ST	0.3	0.6	1.4	1.4	0–4.5	1690.8	0.7	2.2	1.6	1.5–1.7
Breast	12.3	22.7	45.4	40.1	15–67.7	48852.3	19.7	63.8	40.6	40.7–41.5
Cervix uteri	4.9	9.1	18.3	17.4	0.1–36.4	12999.8	5.2	17.0	12.0	11.9–12.3
Corpus uteri	2.8	5.0	10.2	8.6	0–19.6	16964.5	6.8	22.1	13.9	13.8–14.3
Ovaries	2.1	3.9	7.4	9.2	0–23.5	12192.3	4.9	15.9	10.5	10.3–10.7
Kidneys	1.3	2.3	5.3	4.6	0–11.9	6818.3	2.7	8.9	5.5	5.5–5.8
Urinary bladder	0.5	0.9	2.0	2.2	0–6.9	2621.6	1.1	3.4	1.7	1.7–1.8
Brain/CNS	0.3	0.6	1.4	1.3	0–4.1	2841.3	1.1	3.7	3.1	3–3.2
Thyroid gland	2.2	3.9	8.2	5.7	0–13.3	6990.9	2.8	9.1	6.6	6.6–7
Lymphoid/HT	2.3	4.2	8.3	10.1	0–24.1	10997.6	4.4	14.4	10.4	10.2–10.7
Other sites	2.3	4.1	0.0	0.0	0–0	13608.8	5.5	0.0	0.0	0.0
All sites	54.5	100.0	201.8	211.8	150.4–288.5	248091.9	100.0	323.7	192.5	192.9–194.6

RSJ=rectum-sigmoid junction, MSN=malignant skin neoplasm, ST=soft tissues, HT=hematopoietic tissues, CNS=central nervous system.

Appendix Table III. Average annual number of deaths, percent, crude and age-standardized cancer mortality rates (ASMR) per 100,000 among men in Chukotka and Russian Federation, 1999–2010

	Chukotka					Russia
Male	Deaths/year	%	Crude	ASMR	95% CI	Deaths/year	%	Crude	ASMR	95% CI
Lips/oral cavity/pharynx	1.8	4.4	6.4	6.9	0–15.5	7103.9	4.5	10.7	8.6	8.4–8.8
Oesophagus	3.1	7.3	10.2	13.2	0–29.8	5247.5	3.3	7.9	6.3	6.2–6.5
Stomach	5.4	13.3	18.7	41.3	0–85.3	22389.5	14.3	33.7	26.6	26.2–27
Small intestine	0.1	0.2	0.3	0.2	0–0.6	519.3	0.3	0.8	0.6	0.6–0.7
Colon	2	5	7.1	11.2	0–28.6	8255.9	5.3	12.4	9.8	9.6–10
Rectum/RSJ/anus	2.2	5.3	7.7	9.7	0–24.1	8014	5.1	12.1	9.5	9.3–9.7
Liver/bile ducts	2.5	6.1	8	11.3	0–27	4636.5	3	7	5.6	5.4–5.7
Pancreas	1.5	3.6	5.1	8.2	0–21.5	7158.5	4.6	10.8	8.6	8.3–8.8
Other digestive organs	0.2	0.5	0.6	0.3	0–1	1536.3	1	2.3	1.8	1.7–1.9
Larynx	1.5	3.6	4.9	6.4	0–15.2	4914.5	3.1	7.4	5.9	5.7–6.1
Lung/trachea/bronchi	13.1	32	45.3	61.4	17.9–97.8	45412.6	28.9	68.3	54.2	53.7–54.7
Other respiratory organs	0.3	0.7	0.9	0.7	0–2	1064.7	0.7	1.6	1.3	1.2–1.4
Bones/cartilages	0.3	0.7	0.7	1.1	0–2.9	1121.5	0.7	1.7	1.4	1.3–1.5
Skin melanoma	0.5	1.4	2	1.3	0–3.9	1335.5	0.9	2	1.6	1.5–1.7
Other MSN	0	0	0	0	0–0	757.7	0.5	1.2	0.9	0.8–1
Connective/other ST	0.6	1.6	2.1	1.7	0–4.9	1451.3	0.9	2.2	1.8	1.7–1.9
Prostate	0.5	1.4	2.1	2.6	0–7	8248.6	5.3	12.4	9.8	9.6–10
Other male genital organs	0.4	0.9	1.4	1.3	0–3	710.9	0.5	1.1	0.9	0.8–0.9
Kidneys	1.1	2.7	4	5	0–12.9	4841.1	3.1	7.3	5.8	5.7–6
Urinary bladder	1	2.4	3.5	3.7	0–7.7	5628.7	3.6	8.5	6.7	6.5–6.9
Other urinary organs	0	0	0	0	0–0	355.5	0.2	0.5	0.5	0.4–0.5
Brain/CNS	0.9	2.2	3.2	2.4	0–5.7	3098.8	2	4.7	4	3.8–4.1
Lymphoid/HT	1.4	3.2	4.6	4.6	0–11.5	7266.6	4.6	10.9	9.1	8.9–9.4
Other sites	0.7	1.8	0	0	0	5828.6	3.7	0	0	0
All sites	40.9	100	141.1	199.8	113.5–286.1	15689.8	100	236	188.3	187.3–189.2

RSJ=rectum-sigmoid junction, MSN=malignant skin neoplasm, ST=soft tissues, HT=hematopoietic tissues, CNS=central nervous system.

Appendix Table IV. Average annual number of deaths, percent, crude and age-standardized cancer mortality rates (ASMR) per 100,000 among women in Chukotka and Russian Federation, 1999–2010

	Chukotka					Russia
Female	Deaths/year	%	Crude	ASMR	95% CI	Deaths/year	%	Crude	ASMR	95% CI
Lips/oral cavity/pharynx	0.3	1.1	0.9	0.7	0–2	1563.2	1.2	2	1.1	1.1–1.2
Oesophagus	1.4	5.5	5	7.8	0–19.6	1569.3	1.2	2	0.9	0.9–1
Stomach	2.9	11.2	10.7	13.4	0–30.2	16772.4	12.7	21.9	10.9	10.7–11.1
Small intestine	0.1	0.4	0.4	1	0–3	612.2	0.5	0.8	0.4	0.4–0.4
Colon	2.6	10.4	9.8	14.7	0–31.9	11745.1	8.9	15.4	7.4	7.2–7.5
Rectum/RSJ/anus	1	4	3.6	4.1	0–11	8422.8	6.4	11	5.4	5.3–5.6
Liver/bile ducts	0.9	3.7	3.4	4	0–9.9	3613.7	2.7	4.7	2.4	2.3–2.5
Pancreas	0.6	2.6	2.6	3.3	0–8.5	6834	5.2	8.9	4.4	4.3–4.5
Other digestive organs	0.3	1	1	1.6	0–4.7	2691.8	2	3.5	1.7	1.6–1.8
Larynx	0.3	1	1.1	0.6	0–1.9	239.5	0.2	0.3	0.2	0.2–0.2
Lung/trachea/bronchi	5.5	21.1	21	28.8	2.9–49.1	8555.2	6.5	11.2	5.7	5.6–5.8
Other respiratory organs	0.1	0.3	0.4	0.7	0–2.2	597.3	0.5	0.8	0.5	0.4–0.5
Bones/cartilages	0.1	0.5	0.4	0.6	0–1.9	819.2	0.6	1.1	0.7	0.6–0.8
Skin melanoma	0.5	1.6	1.7	1	0–2.9	1616.1	1.2	2.1	1.2	1.2–1.3
Other MSN	0.1	0.3	0.4	1.2	0–3.6	930.8	0.7	1.2	0.6	0.5–0.6
Connective/other ST	0.3	1.2	1.1	1.4	0–4.1	1605.9	1.2	2.1	1.3	1.2–1.4
Breast	3	11.6	11.6	12.6	0–27.5	22467.4	17	29.3	17.2	17–17.4
Cervix uteri	1.1	4.3	4.3	5.7	0–14.7	6156.8	4.7	8	5.1	4.9–5.2
Corpus uteri	1.2	4.4	4.5	5.1	0–12.3	6236.4	4.7	8.1	4.4	4.3–4.5
Ovaries	0.7	3	2.7	6.3	0–18	7429.2	5.6	9.7	5.7	5.6–5.9
Kidneys	0.4	1.2	1.4	1.9	0–5.1	3035	2.3	4	2.1	2–2.2
Urinary bladder	0.4	1.5	1.4	2.2	0–6.5	1390.6	1.1	1.8	0.8	0.7–0.8
Other urinary organs	0	0	0	0	0	195.3	0.1	0.2	0.1	0.1–0.2
Brain/CNS	0.5	2	2.3	1.6	0–4.7	2885.1	2.2	3.8	2.8	2.7–2.9
Lymphoid/HT	0.7	2.8	2.8	4.4	0–11.2	7087.3	5.4	9.2	5.8	5.7–6
Other sites	0.7	3.3	0	0	0	7097.4	5.4	0	0	0
All sites	25.6	100	97	129	69.6–188.5	132168.8	100	172.6	93.5	92.9–94

RSJ=rectum-sigmoid junction, MSN=malignant skin neoplasm, ST=soft tissues, HT=hematopoietic tissues, CNS=central nervous system.

Fig. 1.  Age-standardized incidence rates (ASIR per 100,000) of cancer (all sites combined) among men and women in Chukotka and Russian Federation, 1997–2010.

Fig. 2.  Age-standardized mortality rates (ASMR per 100,000) of cancer (all sites combined) among men and women in Chukotka and Russian Federation, 1999–2010.